FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Bone Grafting Material, Dental, With Biologic Component
PMA: P040013
·
Supplement: S024
·
Decision Dec 4, 2020
Classifications
1
FEI Numbers
6
Registration Numbers
6
Basic Information
- Device Name
- Bone Grafting Material, Dental, With Biologic Component
- Trade Name
- GEM21S Growth Factor Enhanced Matrix
- PMA Number
- P040013
- Supplement Number
- S024
- Device Class
- FDA Class 3
- Product Code
- NPZ
- Generic Name
- Bone grafting material, dental, with biologic component
- Regulation Number
- 872.3930
- Medical Specialty
- Dental
- Advisory Committee
- Dental
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- December 4, 2020
- Date Received
- April 17, 2020
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Change in supplier for the formulation, filling, and testing (with the exception of the Bioassay) of the rhPDGF-BB syringe component of GEM21S Growth Factor Enhanced Matrix to a manufacturing site located at Pyramid Laboratories, Inc., 3598 Cadillac Ave., Costa Mesa, CA 92626.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NPZ | Bone Grafting Material, Dental, With Biologic Component | FDA class 3 | Dental |